loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: bydureon

    Menu

    bydureon

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 209210 / DOSAGE - SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS - 2MG/0.85ML (2MG/0.85ML)

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    EXENATIDE(UNII: 9P1872D4OL)
    (EXENATIDE - UNII:9P1872D4OL)     		EXENATIDE2mg in 0.85

    Inactive Ingredients

    Ingredient Name
    AstraZeneca Pharmaceuticals LP
    MEDIUM-CHAIN TRIGLYCERIDES(C9H2L21V7U)
    POLY(DL-LACTIC-CO-GLYCOLIC ACID), (50:50; 63000 MW)(QD923V64H3)
    SUCROSE(C151H8M554)